| Rebecca Ferlazzo, PT | |
|
124 Hebron Ave Ste 1d, Glastonbury, CT 06033-2039 | |
| (860) 781-6999 | |
| Not Available |
| Full Name | Rebecca Ferlazzo |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 124 Hebron Ave Ste 1d, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083471320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Ferlazzo, PT 47 N Main St, West Hartford, CT 06107-1926 Ph: (860) 409-4595 | Rebecca Ferlazzo, PT 124 Hebron Ave Ste 1d, Glastonbury, CT 06033-2039 Ph: (860) 781-6999 |
News Archive
The first study documenting methicillin-resistant Staphylococcus aureus (MRSA) in swine and swine workers in the United States has been published by University of Iowa researchers.
In a first of its kind study, Mount Sinai researchers have discovered the conditions by which specific signals in primary tumors of head and neck and breast cancers, pre-program cancer cells to become dormant and evade chemotherapy after spreading.
Researchers at Shiley-Marcos Alzheimer's Disease Research Center, part of University of California San Diego School of Medicine, report that autopsies of patients diagnosed with Alzheimer's disease when they were alive - and confirmed by autopsy - indicate many cognitive issues symptomatic of the condition are less noticeable in living Hispanic patients.
Finding out what drugs can be used to treat a patient with tuberculosis (TB) can be sped up by days or weeks, thanks to a new free online tool. The new TB-Profiler tool, developed by a team of scientists led by Dr Taane Clark at the London School of Hygiene & Tropical Medicine, analyses and interprets genome sequence data to predict resistance to 11 drugs used for the treatment of TB.
Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.
› Verified 6 days ago
Naomi Mazur, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 345 Western Blvd, Glastonbury, CT 06033 Phone: 860-549-8975 | |
Dr. Elizabeth Richter Twombly, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 72 Salmon Brook Dr, Glastonbury, CT 06033 Phone: 860-633-5244 | |
Brian R Wally, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2520 Main St Ste 2, Glastonbury, CT 06033 Phone: 860-430-8383 Fax: 860-856-6945 | |
Jareth Cardoso, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2928 Main St Ste 2, 200, Glastonbury, CT 06033 Phone: 860-430-2344 Fax: 860-430-2349 | |
Sally A Burgess, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2345 Main St, Glastonbury, CT 06033 Phone: 800-998-0880 | |
Sarah Jendza, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2520 Main St, Glastonbury, CT 06033 Phone: 860-430-8383 Fax: 860-856-6945 |